PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NuLiv Science

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

NuLiv Science Appoints Brian Peotter As New Vice President of Sales - Brian Peotter brings more than 15 years of experience in the industry - NuLivUSA.com
NuLiv Science Appoints Brian Peotter As New Vice President of Sales

 

NewswireToday - /newswire/ - Walnut, CA, United States, 2014/02/25 - Brian Peotter brings more than 15 years of experience in the industry - NuLivUSA.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

NuLiv Science, a scientifically proven all natural ingredient supplier specializing in sports nutrition and health essentials, today announced that Brian Peotter will be joining NuLiv Science as the Vice President of Sales, reporting to President Michael Wang.

Brian brings more than 15 years of sales experience in the ingredient industry. He will be taking over all national and worldwide sales efforts of NuLiv Science.

Brian comes to NuLiv Science previously from ESM Technologies as the West Regional Sales Manager, where he managed branded ingredient sales in all dietary channels and immensely improved revenue and sales operations. Prior to ESM Technologies, he served as the Director of Business Development for Unigen and was responsible for managing global branded ingredient sales and was counted on to set up and train distributors for branded ingredients.

“Brian has demonstrated the leadership and proven experience to develop and deliver outstanding sales operations and profits.” said Michael Wang, President of NuLiv Science.”We are extremely excited to have Brian running our national and worldwide sales efforts as he brings impeccable sales experience in the ingredient industry.”

“I am excited to have the opportunity to work for the NuLiv Science team in promoting our high quality branded ingredients in North Americas as well as to other worldwide markets.” said Brian Peotter, VP of Sales.”I am honored to be a part of the great team and look forward to growing the business for NuLiv Science.”

Brian is a graduate of the University of Minnesota with a Bachelor’s in Political Science- International Relations Focus. Brian will mostly be traveling to visit and set up meetings with his mass amount of industry contacts and leads he will attain.

About NuLiv Science

Established in 1997, NuLiv Science is a global supplier and developer of natural ingredients for the nutraceutical industry. We specialize in the research and development of proprietary and clinically proven nutraceutical, cosmeceutical and food ingredients through a unique platform of integrated traditional and pharmaceutical grade. NuLiv Science is the proud developer of Astragin, ActiGin, InnoSlim, Astrion, OsteoSine, Verbosnol and CordycepsPrime.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NuLiv Science

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


NuLiv Science Appoints Brian Peotter As New Vice President of Sales

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Andrew Gonzales - NuLivScience.com 
909-594-3188
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NuLiv Science securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NuLiv Science / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)